In an attempt to evaluate the advantages of following a Chinese heart-healthy diet compared to a control, the DECIDE-Diet trial set out to examine Chinese individuals with mild hypertension.
Most Recent Articles
Study to Explore Cangrelor vs. Glycoprotein IIa/IIb Inhibitors to Bridge or Not to Bridge In the Periprocedural Settings
During dual antiplatelet therapy, Cangrelor or eptifibatide, etc., short-acting parental antithrombotics may be considered in the first three months of post percutaneous coronary intervention as compared to aspirin and oral P2Y12...
Hemodynamic Trial Study to Show Riociguat Outcomes In Patients of Heart Failure With Pulmonary Hypertension and Preserved Ejection Fraction
The DYNAMIC trial study was a randomized, multicenter, placebo-controlled, double-blind IIB trial between 5 hospitals across Germany and Austria. A sample of 58 patients for riociguat and 56 for placebo therapy was selected. The...
Trial to Study Comprehensive Lifestyle Intervention for Cardiovascular Disease Prognosis and Prevention
Eligible asymptomatic individuals between the age range 40-50 years from the progression of early sub-clinical atherosclerosis cohort were selected through stratified randomization sample techniques in Spain. Stratification was...
VISUALIZED: Trial Study to Show Empagliflozin Outcomes In Patients of Chronic Heart Failure and Reduced Ejection Fraction—EMPEROR-Reduced
Read further: Trial Study to Show Empagliflozin Outcomes In Patients of Chronic Heart Failure and Reduced Ejection Fraction—EMPEROR-Reduced
